Bardia, A. (2018). Targeted Therapy for Premenopausal Women with HR+, HER2- Advanced Breast Cancer: Focus on Special Considerations and Latest Advances. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationBardia, A. Targeted Therapy for Premenopausal Women with HR+, HER2- Advanced Breast Cancer: Focus on Special Considerations and Latest Advances. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationBardia, A. Targeted Therapy for Premenopausal Women with HR+, HER2- Advanced Breast Cancer: Focus on Special Considerations and Latest Advances. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.